ResearchSpace

Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters

Show simple item record

dc.contributor.author Tshweu, L
dc.contributor.author Katata, L
dc.contributor.author Naidoo, Saloshnee
dc.contributor.author Kalombo, Lonji
dc.contributor.author Swai, H
dc.date.accessioned 2012-11-01T06:46:21Z
dc.date.available 2012-11-01T06:46:21Z
dc.date.issued 2012-10
dc.identifier.citation Tshweu, L., Katata, L., Naidoo, S., Kalombo, L. and Swai, H. Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters. 4th CSIR Biennial Conference: Real problems relevant solutions, CSIR, Pretoria, 9-10 October 2012 en_US
dc.identifier.uri http://hdl.handle.net/10204/6262
dc.description 4th CSIR Biennial Conference: Real problems relevant solutions, CSIR, Pretoria, 9-10 October 2012 en_US
dc.description.abstract AIDS kills over 1.5 million people a year globally. Current HIV drugs pose many challenges. This presentation shows that nano-encapsulation of HIV drugs achieves controlled and steady drug release, and reduced dosing frequency. en_US
dc.language.iso en en_US
dc.subject AIDS en_US
dc.subject HIV en_US
dc.subject anti-HIV drugs en_US
dc.subject Nano-encapsulation en_US
dc.subject Dosing frequency en_US
dc.title Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters en_US
dc.type Conference Presentation en_US
dc.identifier.apacitation Tshweu, L., Katata, L., Naidoo, S., Kalombo, L., & Swai, H. (2012). Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters. http://hdl.handle.net/10204/6262 en_ZA
dc.identifier.chicagocitation Tshweu, L, L Katata, Saloshnee Naidoo, Lonji Kalombo, and H Swai. "Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters." (2012): http://hdl.handle.net/10204/6262 en_ZA
dc.identifier.vancouvercitation Tshweu L, Katata L, Naidoo S, Kalombo L, Swai H, Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters; 2012. http://hdl.handle.net/10204/6262 . en_ZA
dc.identifier.ris TY - Conference Presentation AU - Tshweu, L AU - Katata, L AU - Naidoo, Saloshnee AU - Kalombo, Lonji AU - Swai, H AB - AIDS kills over 1.5 million people a year globally. Current HIV drugs pose many challenges. This presentation shows that nano-encapsulation of HIV drugs achieves controlled and steady drug release, and reduced dosing frequency. DA - 2012-10 DB - ResearchSpace DP - CSIR KW - AIDS KW - HIV KW - anti-HIV drugs KW - Nano-encapsulation KW - Dosing frequency LK - https://researchspace.csir.co.za PY - 2012 T1 - Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters TI - Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters UR - http://hdl.handle.net/10204/6262 ER - en_ZA


Files in this item

Thumbnail
Name: Tshweu_2012.pdf
Size: 1.138Mb
Format: PDF
View/Open

This item appears in the following Collection(s)

Show simple item record